ENDO USA, Inc. recalls Buprenorphine Hydrochloride
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Crystallization; identified as Buprenorphine free base
- Products
-
- Buprenorphine Hydrochloride
- Company
- ENDO USA, Inc.
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 34,293 vials
- About this recall
- Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.